A phase II trial of paclitaxel and epirubicin in advanced breast cancer

Initial trials of paclitaxel and doxorubicin in advanced breast cancer yielded high response rates but significant cardiac toxicity was observed. In this phase II trial we investigated the efficacy and safety of paclitaxel combined with epirubicin. Patients with advanced breast cancer, performance s...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Rischin, D, Smith, J, Millward, M, Lewis, C, Boyer, M, Richardson, G, Toner, G, Gurney, H, McKendrick, J
Formato: Artigo
Idioma:English
Publicado: Nature Publishing Group 2000
Assuntos:
Regular Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC2374646/
https://ncbi.nlm.nih.gov/pubmed/10945487
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1054/bjoc.2000.1306
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Internet

https://ncbi.nlm.nih.gov/pmc/articles/PMC2374646/
https://ncbi.nlm.nih.gov/pubmed/10945487
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1054/bjoc.2000.1306

Títulos similares